Vir Biotechnology, Inc. — Director's Dealing 2019

Oct 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2019-10-16

Reporting Person: SHARP PHILLIP A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-10-16	Common Stock	C	88888	—	Acquired	105368	Direct
2019-10-16	Common Stock	C	44444	—	Acquired	44444	Indirect
2019-10-16	Common Stock	C	44444	—	Acquired	44444	Indirect
2019-10-16	Common Stock	C	44444	—	Acquired	44444	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-10-16	Series A-1 Convertible Preferred Stock	$	C	88888	Disposed		Common Stock (88888)	Direct
2019-10-16	Series A-1 Convertible Preferred Stock	$	C	44444	Disposed		Common Stock (44444)	Indirect
2019-10-16	Series A-1 Convertible Preferred Stock	$	C	44444	Disposed		Common Stock (44444)	Indirect
2019-10-16	Series A-1 Convertible Preferred Stock	$	C	44444	Disposed		Common Stock (44444)	Indirect

Footnotes

F1: Each share of the Issuer's Series A-1 Convertible Preferred Stock (the "Preferred Stock") automatically converted into one share of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.

F2: The shares are held by the Phillip A. Sharp Irrevocable Trust 11/04/08 FBO Sarah Brokaw, over which the reporting person's spouse is co-trustee.

F3: The shares are held by the Phillip A. Sharp Irrevocable Trust 11/04/08 FBO Helena Sharp, over which the reporting person's spouse is co-trustee.

F4: The shares are held by the Phillip A. Sharp Irrevocable Trust 11/04/08 FBO Christine Carey, over which the reporting person's spouse is co-trustee.